SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-002680
Filing Date
2019-01-25
Accepted
2019-01-24 17:53:51
Documents
5
Period of Report
2019-01-23
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv511477_8k.htm 8-K 34442
2 EXHIBIT 3.1 tv511477_ex3-1.htm EX-3.1 7931
3 EXHIBIT 10.1 tv511477_ex10-1.htm EX-10.1 132504
4 EXHIBIT 99.1 tv511477_ex99-1.htm EX-99.1 9779
5 GRAPHIC image_001.jpg GRAPHIC 9884
  Complete submission text file 0001144204-19-002680.txt   199738
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 19540803
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1